Terms: = Pancreatic cancer AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE AND Prognosis
13 results:
1. Depletion of
Yoshizawa M; Shiozaki A; Ashihara E
Cancer Genomics Proteomics; 2024; 21(1):18-29. PubMed ID: 38151292
[TBL] [Abstract] [Full Text] [Related]
2. SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy.
Zheng X; Lin J; Xiong J; Guan Y; Lan B; Li Y; Gao X; Fei Z; Chen L; Chen L; Chen L; Chen G; Guo Z; Yi X; Cao W; Ai X; Zhou C; Li X; Zhao J; Yan X; Yu Q; Si L; Chen Y; Chen C
BMC Cancer; 2023 Jul; 23(1):686. PubMed ID: 37479966
[TBL] [Abstract] [Full Text] [Related]
3. Tumor-suppressive role of microfibrillar associated protein 4 and its clinical significance as prognostic factor and diagnostic biomarker in hepatocellular carcinoma.
Li J; Wang J; Liu Z; Guo H; Wei X; Wei Q; Zheng S; Xu X
J Cancer Res Ther; 2022 Dec; 18(7):1919-1925. PubMed ID: 36647950
[TBL] [Abstract] [Full Text] [Related]
4. nc-RNA-mediated high expression of cdk6 correlates with poor prognosis and immune infiltration in pancreatic cancer.
Zhao YX; Xu BW; Wang FQ; Jiang FY; Xu JW; Yu DX
Cancer Med; 2023 Feb; 12(4):5110-5123. PubMed ID: 36457244
[TBL] [Abstract] [Full Text] [Related]
5. Silencing of KNTC1 inhibits hepatocellular carcinoma cells progression via suppressing PI3K/Akt pathway.
Tong H; Liu X; Peng C; Shen B; Zhu Z
Cell Signal; 2023 Jan; 101():110498. PubMed ID: 36273753
[TBL] [Abstract] [Full Text] [Related]
6. KDM1A and KDM3A promote tumor growth by upregulating cell cycle-associated genes in pancreatic cancer.
Hou X; Li Q; Yang L; Yang Z; He J; Li Q; Li D
Exp Biol Med (Maywood); 2021 Sep; 246(17):1869-1883. PubMed ID: 34171978
[TBL] [Abstract] [Full Text] [Related]
7. GSG2 knockdown suppresses cholangiocarcinoma progression by regulating cell proliferation, apoptosis and migration.
Zhou J; Nie W; Yuan J; Zhang Z; Mi L; Wang C; Huang R
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846801
[TBL] [Abstract] [Full Text] [Related]
8. The RNA-binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma.
Panzeri V; Manni I; Capone A; Naro C; Sacconi A; Di Agostino S; de Latouliere L; Montori A; Pilozzi E; Piaggio G; Capurso G; Sette C
Mol Oncol; 2021 Feb; 15(2):579-595. PubMed ID: 33159833
[TBL] [Abstract] [Full Text] [Related]
9. miR-3613-5p enhances the metastasis of pancreatic cancer by targeting cdk6.
Cao R; Wang K; Long M; Guo M; Sheng L; Zhan M; Yang R; Wang H; Yang L
Cell Cycle; 2020 Nov; 19(22):3086-3095. PubMed ID: 33073681
[TBL] [Abstract] [Full Text] [Related]
10. The histopathologic type predicts survival of patients with ampullary carcinoma after resection: A meta-analysis.
Zhou Y; Li D; Wu L; Si X
Pancreatology; 2017; 17(2):273-278. PubMed ID: 28131524
[TBL] [Abstract] [Full Text] [Related]
11. Elevated GRP78 expression is associated with poor prognosis in patients with pancreatic cancer.
Niu Z; Wang M; Zhou L; Yao L; Liao Q; Zhao Y
Sci Rep; 2015 Nov; 5():16067. PubMed ID: 26530532
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathological features of giant cell carcinoma of the pancreas.
Zou XP; Yu ZL; Li ZS; Zhou GZ
Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):300-2. PubMed ID: 15138131
[TBL] [Abstract] [Full Text] [Related]
13. Adenovirus-mediated wt-p16 reintroduction induces cell cycle arrest or apoptosis in pancreatic cancer.
Calbó J; Marotta M; Cascalló M; Roig JM; Gelpí JL; Fueyo J; Mazo A
Cancer Gene Ther; 2001 Oct; 8(10):740-50. PubMed ID: 11687897
[TBL] [Abstract] [Full Text] [Related]
